Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress.

Ramalho, Theresa; Pereira, Nayara; Brandt, Stephanie L; Serezani, C Henrique

Ramalho, Theresa; Pereira, Nayara; Brandt, Stephanie L; Serezani, C Henrique.

Afiliación

Ramalho T; Department of Immunology, University of Sao Paulo, Sao Paulo, Brazil.
Pereira N; Department of Immunology, University of Sao Paulo, Sao Paulo, Brazil.
Brandt SL; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Serezani CH; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. h.serezan@vanderbilt.edu.

Adv Exp Med Biol ; 1274: 55-69, 2020.

Article en En | MEDLINE | ID: mdl-32894507

Asunto(s)

Comorbilidad; Antagonistas de Leucotrieno/uso terapéutico; Leucotrienos/metabolismo; Enfermedades Metabólicas/complicaciones; Enfermedades Metabólicas/prevención & control; Estrés Fisiológico; Asma; Aterosclerosis; Humanos

Palabras clave

Clinical trials; Diabetes; Immune regulation; Inflammation; Leukotrienes; Metabolic disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estrés Fisiológico / Comorbilidad / Leucotrienos / Antagonistas de Leucotrieno / Enfermedades Metabólicas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google